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PPARγ coactivator-1α (PGC-1α) is considered to be a major regulator of mitochondrial biogenesis. Though ﬁrst discovered in
brown adipose tissue, this coactivator has emerged as a coordinator of mitochondrial biogenesis in skeletal muscle via enhanced
transcription of many nuclear genes encoding mitochondrial proteins. Stimuli such as exercise provoke the activation of signalling
cascades that lead to the induction of PGC-1α. Posttranslational modiﬁcations also regulate the function of PGC-1α,w i t ha
multitude of upstream molecules targeting the protein to modify its activity and/or expression. Previous research has established
a positive correlation between resistance to fatigue and skeletal muscle mitochondrial content. Recently, studies have begun
to elucidate the speciﬁc role of PGC-1α in exercise-related skeletal muscle adaptations, with several studies identifying it as a
dominant regulator of organelle synthesis. This paper will highlight the function, regulation, and expression of PGC-1α,a sw e l la s
the role of the coactivator during exercise adaptations.
1.Introduction
The PPARγ coactivator-1 (PGC-1) family of coactivators is a
well studied group of coregulatory proteins. These proteins
are classiﬁed as second-class coactivators and consist of
PPARγ coactivator-1α (PGC-1α), -1β (PGC-1β), and PGC-
1-related coactivator (PRC). All three PGC-1 members share
a basic protein structure consisting of an activation domain
with the LXXLL sequence in the N-terminal, a central
region associated with repression, and a RNA-binding motif
(RMM) and serine-arginine-rich (RS) region in the C-
terminal region [1]. Collectively, PGC-1 coactivators have
emerged as major regulators of multiple cellular processes,
including adaptive thermogenesis, glucose metabolism, and
muscle ﬁber type specialization, and they are considered to
be predominantly involved in the regulation of mitochon-
drial content and function [2–6]. While all three PGC-1
family members are implicated in the regulation of mito-
chondrial biogenesis, PGC-1α is the most well-characterized
of the group. PGC-1β was ﬁrst discovered based on its
sequence similarity to PGC-1α [7, 8], and much research
on PGC-1β has been focused on its function speciﬁcally
in relation to PGC-1α, in particular it’s involvement in the
regulation of mitochondrial content and oxygen respiration
[9]. Conversely, the role of PRC remains to be well-deﬁned.
Research thus far has also implicated PRC in the regulation
of mitochondrial respiratory function, along with a role
in cell cycle progression, whereby PRC is upregulated in
proliferating cells, and responsive to serum growth factors
[10–12]. In contrast, a multitude of studies have revealed a
dominant role of PGC-1α in the regulation of mitochondrial
content, and based on the plethora of data to support this, it
is not surprising that the coactivator is currently considered
one of the most important regulators of mitochondrial
biogenesis [4].
2.PGC-1αFunction
PGC-1α is the founding member of the PGC-1 family
of coactivators that was originally identiﬁed based on its2 PPAR Research
functionalinteractionwiththetranscriptionfactorPPARγ in
brown adipose tissue [4]. The gene for PGC-1α is located on
chromosomefourinhumans(chromosomeﬁveinmice)and
encodes a protein consisting of 798 amino acids (797 amino
acids in mice) with a predicated molecular weight of 92kDa
[13].
PGC-1α does not contain intrinsic enzymatic activities,
rather several proteins containing histone acetyltransferase
(HAT) activity bind to the activation domain on the N-
terminal of PGC-1α when the coactivator is bound to a
transcription factor. The binding of these proteins, such as
p300, SRC-1, and CREB-binding protein (CBP) to PGC-1α,
remodels histones onchromatinandallowsforgreateraccess
of the transcriptional machinery to DNA for gene transcrip-
tion [14]. Neighbouring the N-terminus is a 200 amino
acid negative regulatory region that represses the function of
the activation domain in PGC-1α [14]. At the C-terminus,
proteins that bind, such as the TRAP/DRIP mediator
complex, can aid in the displacement of repressor proteins
such as histone deacetylases (HDACs) which function by
deacetylatinghistones,therebykeepingDNAinacoiledstate.
The displacement of HDACs via the interaction of PGC-
1α and the mediator complex allows for the relaxation of
chromatin, greater access of transcription factors to DNA,
and enhanced gene transcription [15]. The RNA-binding
motif (RMM) and serine-arginine rich region (RS) domains
in the C-terminus are characteristic of proteins with mRNA
splicingandexportactivity[16].IthasbeenfoundthatPGC-
1α associates with RNA polymerase II during elongation and
is also involved in the splicing and export of several mRNA
products [16]. Thus, collectively PGC-1α acts as a platform
to integrate many proteins and processes involved in the
production of mature mRNA transcripts [4, 17].
Early studies examining the function of PGC-1α in
brown adipose tissue suggested a role for PGC-1α in the
regulation of mitochondrial content, termed mitochondrial
biogenesis. For example, analysis of the expression pattern
of PGC-1α across multiple tissues revealed strong corre-
lations between oxidative capacity and protein levels of
the coactivator [5, 16, 18, 19]. Protein and mRNA levels
of PGC-1α are greatest in tissues with a high metabolic
activity, such as brown fat, heart, and skeletal muscle [4,
19]. Since its discovery, there has been an abundance of
research which has pointed out the importance of PGC-1α
in regulating mitochondrial content [4, 5, 19, 20]. As noted
below, PGC-1α is speciﬁcally involved in the maintenance of
mitochondrial function, respiration, and content in skeletal
muscle [4, 5, 20, 21].
The process of mitochondrial biogenesis is complex
becausetheexpansionofthemitochondrialnetworkrequires
the cooperation of both the nuclear and mitochondrial
genomes. Mitochondria contain double-stranded circular
DNA that encodes less than 1% of the proteins necessary for
the electron transport chain (ETC) and organelle function
[22, 23]. Thus, mitochondrial biogenesis is highly dependent
on the expression of proteins encoded by nuclear DNA to
ensure the proper assembly and expansion of the mitochon-
drial reticulum [24]. This eﬀe c ti sm e d i a t e di np a r tb yt h e
ability of PGC-1α to coactivate many transcription factors
that bind to the promoter region of nuclear genes encoding
mitochondrial proteins (NUGEMPs; Figure 1). In particular,
PGC-1α interacts with nuclear respiratory factors (NRF)-1
and -2 to transactivate genes involved in the electron
transportchain(ETC),theproteinimportmachinery,aswell
as transcription factors of mitochondrial DNA (mtDNA),
such as mitochondrial transcription factor A (Tfam) [25,
26]. Recently, the estrogen-related receptor, ERRα, has also
emerged as an important regulator of oxidative metabolism.
ERRα binding sites are present on the promoters of several
genes of the ETC, such as cytochrome c and β-ATP synthase
[27]. Furthermore, ERRα activity is regulated by PGC-1α,
because its ablation compromises the ability of PGC-1α to
induce mitochondrial biogenesis [9]. It is also well estab-
lished that PGC-1α coactivates the PPAR family of nuclear
receptors, such as PPARδ, which induces the expression of
mitochondrial proteins (e.g., cytochrome c oxidase subunit
II (COXII) and COXIV) that are important for biogenesis
[28, 29]. Thus, the ability of PGC-1α to orchestrate the
transcriptional activity of these, and several other nuclear
transcriptionfactors,allowsthecoactivatortocoordinatethe
largenumberofgenesessentialformitochondrialbiogenesis.
3. Regulation of Expression
Alterations in the mitochondrial content of tissues such as
skeletal muscle have a large impact on cellular metabolism
and whole body health. Since PGC-1α is a vital regulator
of mitochondrial content, it is therefore physiologically
relevant to understand, in detail, the regulation of PGC-
1α expression. PGC-1α is induced by multiple factors, such
as environmental, hormonal, and nutritional stimuli across
av a r i e t yo ft i s s u e s[ 19, 30, 31]. In skeletal muscle, PGC-
1α expression tends to coincide with signalling pathways
typically activated with mitochondrial biogenesis, such as
those induced by endurance exercise. These include the
activation of p38 MAP kinase, AMPK, Ca2+-mediated path-
ways involving CaMK, as well as ROS-induced signaling. All
have been mediated in the regulation of PGC-1α promoter
activity.Forexample,activationofcAMPresponsiveelement
binding protein (CREB) and activating transcription factor
2 (ATF2) via either Ca2+/CaMKIV or p38 mitogen-activated
protein kinase (MAPK), respectively, stimulate binding of
CREB to the cAMP responsive element (CRE) in the pro-
moter of PGC-1α [32, 33]. Indeed, overexpression of Ca2+-
activatedCaMKincreasesPGC-1αpromoteractivity[2],and
treatment of muscle cells with caﬀeine to induce an increase
in intracellular cytosolic Ca2+ results in an increase in PGC-
1α expression which is dependent on CaMK activity [34].
Interestingly, the induction of PGC-1α in response to raised
Ca2+ is most likely a result of the downstream activation
of p38 by CaMK, because inhibiting the phosphorylation
of p38 prevents increases in PGC-1α even in the presence
of active CaMK. This eﬀect is likely mediated by p38γ,
not p38α or β [35]. These data suggest that physiological
conditions which evoke elevations in cytosolic calcium, such
as contractile activity, could augment PGC-1α expression via
transcriptional activation of the PGC-1α promoter.PPAR Research 3
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Figure 1:PGC-1αinducesexpressionofnuclearandmitochondrialgenesrequiredfororganellesynthesis.ExpressionofPPARγ coactivator-
1α is regulated by a number of transcription factors (e.g., USF-1, CREB) which associate with its promoter region to augment transcription.
External stimuli, such as exercise, provoke the formation of reactive oxygen species (ROS) and activate AMPK. These signalling molecules
induce PGC-1α transcription (1), and increase coactivator mRNA expression. Upon formation, the nascent transcript is transported to
the cytoplasm. Once translated into protein, PGC-1α is sequestered to the nucleus (2), interacting with transcription factors to promote
the transcription of nuclear genes encoding mitochondrial proteins (NUGEMPs). Speciﬁcally, PGC-1α is known to associate with nuclear
respiratory factors 1 and 2 (NRF-1, NRF-2), guiding the transcription of mitochondrially-destined proteins. NUGEMP mRNA is exported
to the cytoplasm and is subject to translation (3). The translated precursor proteins are imported into the mitochondria (4) via the protein
import machinery (PIM). Many of these form multisubunit complexes that become part of the electron transport chain (ETC). One
particular nuclear-derived protein is mitochondrial transcription factor A (Tfam). Once imported into the mitochondria, it associates with
mitochondrial DNA (mtDNA) (5), directing the production of mtDNA-encoded proteins. These products are then integrated into the ETC
(6). Thus, PGC-1α is an important protein which initiates a cascade of events leading to mitochondrial biogenesis.
Signals which activate AMPK also contribute to an
increase in PGC-1α expression [19]. AICAR treatment, a
known activator of AMPK, increased the mRNA levels of
PGC-1α in myoblasts after only 24 hours of treatment. This
was the result of an AMPK-mediated increase in the binding
of upstream stimulatory factor-1 (USF-1) to a GATA/Ebox
consensussequenceinthePGC-1αpromoter[36].H2O2 also
provoked an increase in PGC-1α transcription, in part by
H2O2-induced binding of USF-1 to the PGC-1α promoter,
along with the activation of AMPK elicited by exogenous
H2O2 levels [37]. Although these are the major pathways
that appear to regulate the transcriptional activity of PGC-
1α, the coactivator is also involved in an autoregulatory
loop controlling its own level of activity. Some transcription
factors that PGC-1α coactivates, such as myocyte enhancer
factor (MEF)-2 and myogenic determining factor (MyoD),
also bind to, and regulate, the PGC-1α promoter [38, 39].
Thus, there are multiple, likely overlapping and redundant,
signaling pathways which mediate the transcription of this
important metabolic coactivator.
4. PosttranslationalModiﬁcations of PGC-1α
Regulation of PGC-1α at the protein level via protein sta-
bility, subcellular localization or activation can also account
for PGC-1α-mediated actions on mitochondrial biogenesis.
The phosphorylation of PGC-1α by p38 MAPK was the
ﬁrst posttranslational modiﬁcation that was identiﬁed which4 PPAR Research
alters protein stability. In skeletal muscle, p38 MAPK phos-
phorylates of multiple serine/threonine residues (Thr262,
Ser265 and Thr298). This results in an increase in PGC-
1α protein levels as a consequence of increased protein
stability from a half-life of 2.3 to 6.3 hours [40]. In contrast,
phosphorylation by Akt on Ser570 results in an unstable
protein with impaired activity [41]. p38 MAPK also has an
additional eﬀect that promotes the release of PGC-1α from
inhibitory factors [42, 43]. Under steady state conditions,
p160myb binding protein (p160MBP) binds to, and represses,
the transcriptional activity of PGC-1α. The p38-mediated
phosphorylation of PGC-1α disrupts the binding of p160MBP
to the coactivator, allowing for its activation [42].
In addition to p38, additional kinases also phosphorylate
and modulate the activity of PGC-1α. AMPK directly
phosphorylates PGC-1α (Thr177 and Ser538), which is
essential for the AICAR-dependent induction of the PGC-
1α promoter [44]. This mechanism may potentially be
involved in the mitochondrial adaptations, such as increases
in cytochrome c and cellular respiration that are provoked
by AICAR [45]. Thus, the activation of AMPK and its
phosphorylation of downstream targets, such as PGC-1α,i s
likely important in the regulation of nuclear genes encoding
mitochondrial proteins in response to exercise.
Additional posttranslational modiﬁcations of PGC-1α
include acetylation and methylation of the protein. The
NAD+-dependent histone deacetylase, silent information
regulator 1 (SIRT1), interacts with PGC-1α and deacetylates
the coactivator on various lysine residues between amino
acids200and400[46,47].ThedeacetylationviaSIRT1keeps
PGC-1α in an active state. In skeletal muscle, the activation
of SIRT1 stimulates the upregulation of mitochondrial gene
expression in a manner that is at least partly due to the
deacetylation of PGC-1α [48]. Conversely, evidence from
neural cells indicates that the deacetylation of PGC-1α by
SIRT1decreasesactivityofthecoactivator[46].Thissuggests
that the eﬀects of SIRT1 on the activity of PGC-1α occur
in a tissue-speciﬁc manner. In contrast to deacetylation,
the acetylation of PGC-1α by general control of amino
acid synthesis 5 (GCN5) acetyltransferase results in a tran-
scriptionally inactive protein [45]. This repression of PGC-
1α is attributed to the acetylation-induced translocation
of the coactivator to nuclear foci where it is inhibited by
the transcriptional corepressor, nuclear receptor interacting
protein 140 (RIP140).
In addition to acetylation, lysine residues on PGC-1α can
also be modiﬁed by small ubiquitin-like modiﬁer (SUMO)
proteins. The sumoylation of proteins has many functions
that can aﬀect protein subcellular localization, stability,
activity, and capacity to interact with other proteins and
activity [49]. PGC-1α can be sumoylated on lysine residue
183 on its activation domain [50]. The addition of SUMO
proteins attenuates the transcriptional activity of PGC-1α by
enhancing the sensitivity of PGC-1α to the repressive actions
of RIP140, independent of any alterations in the localization
or stability of the coactivator [50]. Further identiﬁcation of
the multitude of signals and modiﬁcations which regulate
the activity of PGC-1α will continue to provide a better
understanding of the function of this metabolic regulator.
5. The Effects of PGC-1αOverexpression and
Knockout on Exercise Performance
The majority of research regarding PGC-1α has primarily
involved the overexpression and/or ablation of the pro-
tein using animal and cell culture models. The ectopic
expression of PGC-1α in cultured muscle cells induces
large increases in mitochondrial content and augments both
basal and active cellular respiration rates [5]. In fact, the
overexpression of PGC-1α has repeatedly been shown to
increase levels of NUGEMPs essential for mitochondrial
biogenesis [2, 51]. For example, elevated levels of PGC-1α
in C2C12 cells enhances nuclear- (e.g., cytochrome c, COX
subunit IV) and mitochondrially- (e.g., COX subunit II)
encoded components of the respiratory chain and ampliﬁes
mtDNA copy number [5]. These results have also been
replicated in vivo. Both whole body and muscle-speciﬁc
overexpressing PGC-1α animals display increases in markers
of mitochondrial content along with overall increases in
oxidative capacity. PGC-1α transgenic animals also exhibit
physiological improvements in whole body oxygen uptake
and decreased fatigue in response to an exercise stimulus
[2, 51]. Altering the expression of PGC-1α in vivo has also
revealed an important role of PGC-1α in muscle refuelling.
Gain-of-function experiments resulted in increased muscle
glucose uptake and decreased rates of glycolysis, along with
concomitant increases in muscle glycogen stores and the
preventionofglycogendepletioninresponsetoexercise[52].
Conversely, PGC-1α-deﬁcient animals also reveal the
essential nature of PGC-1α for the normal expression of
mitochondrial genes important for organelle biogenesis [53,
54]. The mRNA levels of both nuclear and mitochondrial
genes are reduced in several tissues, including skeletal muscle
[54]. Lack of PGC-1α also led to a reduced mitochondrial
content, as revealed by COX activity in striated muscle,
along with deﬁcits in mitochondrial function. The ablation
of PGC-1α signiﬁcantly impaired mitochondrial respiration
rates, indicating a diminished ability to produce ATP relative
to wild-type (WT) control animals [20]. These alterations
in mitochondrial content and function relate to the reduced
endurance capacity observed in PGC-1α KO animals [55].
Collectively, the data indicate that the manipulation of PGC-
1α has revealed a very dynamic role for the coactivator that
appearstobecenteredonitsinvolvement intheregulationof
mitochondrial biogenesis.
6. Response to Exercise
It has long been known that exercise elicits changes in the
expression of NUGEMPs and enhances the process of mito-
chondrial biogenesis in skeletal muscle. In fact, the discovery
of PGC-1α gave rise to the possibility that a main regu-
latory protein could control the mitochondrial adaptations
observed with endurance exercise, or in response to chronic
contractile activity (CCA). Thus, PGC-1α has been readily
implicated in mediating exercise-induced mitochondrial
biogenesis. The use of chronic muscle stimulation and acute
exercise paradigms have demonstrated increases in PGC-1α
mRNA and protein levels [19, 31, 56]. As expected, thesePPAR Research 5
exercise models also resulted in the concurrent upregulation
of genes encoded by both the nuclear and mitochondrial
genomes involved in mitochondrial biogenesis [57, 58].
The coordinated changes in the expression of PGC-1α and
NUGEMPs with exercise have founded the basis for a role
of PGC-1α in exercise-induced mitochondrial adaptations in
skeletal muscle.
The particular mechanisms underlying the increases
observed in PGC-1α remain unknown, however, both p38
and AMPK, two kinases known to modify PGC-1α levels,
are activated in response to contractile activity. Evidence
suggests that p38 activation in response to exercise increases
binding of MEF2 and ATF2 to the promoter of PGC-1α
[32]. AMPK is also phosphorylated with contractile activity
in skeletal muscle. Furthermore, AMPK has been shown
to regulate PGC-1α during states of energy deprivation,
such as in the case of exercise [59]. Surprisingly, exercise-
inducedactivationofPGC-1αwasunalteredinAMPKα1and
AMPKα2K Om i c e[ 60]. This suggests that the induction of
PGC-1α with exercise may be AMPK-independent, or that
other kinases are able to compensate for the partial loss of
AMPK. Further investigation into the initial signals mediat-
ing PGC-1α expression with exercise is necessary to better
understand the involvement of PGC-1α on mitochondrial
biogenesis.
Much of the current research regarding PGC-1α is
focused on determining whether the coactivator directly
mediates exercise-induced mitochondrial adaptations. Early
work suggested that PGC-1α may be involved, but that
it does not appear to be necessary for increases in the
expression of NUGEMPs in response to an endurance
trainingregime[61].Timecourseanalysesrevealedincreased
binding of NRF-1 and -2 to the cytochrome C and COXIV
promoters, respectively, along with corresponding mRNA
changes that precede the increased expression of PGC-1α
[61]. These results suggest that the activation, rather than
the expression of PGC-1α in response to exercise may be
regulating the rapid initial changes in the mRNA level of
NUGEMPs.
T h ei m p o r t a n c eo fP G C - 1 α in regulating mitochondrial
biogenesis in response to exercise has further been examined
inPGC-1αtransgenicanimals.Researchwithmuscle-speciﬁc
PGC-1α overexpressing mice has demonstrated the ability
of the coactivator to improve exercise performance, as
revealed by greater times to exhaustion [51]. This strongly
suggests the potential involvement of PGC-1α in exercise-
induced adaptations. Findings supportive of this have also
been noted in animals lacking the coactivator. PGC-1α
KO mice have an impaired endurance capacity, as well
reduced levels of key mitochondrial proteins [55]. However,
skeletal muscles from PGC-1α KO mice display similar-fold
increases in the expression of mitochondrial proteins in
response to endurance training, compared to WT animals
[62]. Contrary to this, muscle-speciﬁc deletion of PGC-
1α attenuates exercise-induced mitochondrial adaptations,
such as increases in cytochrome c and COXIV protein
[63]. Pogozelski et al. [35] have also demonstrated that
the p38γ MAPK-dependent increase in PGC-1α is required
for endurance exercise-induced mitochondrial biogenesis.
In addition, data from our laboratory also indicate that
chronic contractile activity- (CCA-) induced levels of PGC-
1α are necessary for the typical mitochondrial adaptations in
response to contractile activity (Uguccioni, AJP). Thus, these
data reveal the likelihood that multiple pathways, including
PGC-1α-mediated gene expression, are involved in exercise-
inducedmitochondrialbiogenesis.Theidentityofalternative
pathwaysthatmayprovokeorganellesynthesisintheabsence
of PGC-1α remain to be fully discovered.
7. Conclusion
PGC-1α is a powerful coactivator of gene expression leading
to mitochondrial biogenesis in muscle. Since muscle occu-
pies a large portion of body mass, changes in mitochondrial
contenthaveasigniﬁcantimpactonwholebodymetabolism.
Thus, the continued development of our understanding
of the physiological and pharmacological conditions that
regulate PGC-1α expression and function in muscle, and
other tissues, is important for the optimization of whole
body metabolic health.
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